Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
E. Elfimova, Y. Andreeva, Z. N. Sukmarova, A. Y. Litvin, I. E. Chazova, A. N. Rogoza (Moscow, Russian Federation). Vascular effects of CPAP – Therapy in patients with arterial hypertension and severe OSA. Eur Respir J 2010; 36: Suppl. 54, 937

Member's Comments

No comment yet.

Related content which might interest you: Obstructive sleep apnea syndrome as an arterial hypertension risk factor – clinical study Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Acute haemodynamic effects of adaptive servoventilation therapy in patients with pulmonary arterial hypertension and patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Acute and chronic effects of PDE5-Is on SpO2 in patients with COPD associated pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Treatment of pulmonary arterial hypertension in elderly and very elderly patients Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Everolimus improves exercise capacity and pulmonary vascular resistance in patients with advanced pulmonary hypertension – A pilot study Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Investigation of frequency of OSAS in patients with pulmonary hypertension by polysomnography Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Correction of endothelial dysfunction in patients with COPD and concomitant arterial hypertension Source: International Congress 2015 – COPD: interesting notes Year: 2015 Obesity hypoventilation syndrome – retrospective study and efficacy of positive airway pressure Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009 Beta-blocker therapy nor hyperoxic breathing lowers ventilatory drive in pulmonary arterial hypertension patients Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange Year: 2014 Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 768s Year: 2007 Positive effect of CPAP treatment on the control of difficult-to-treat hypertension Source: Eur Respir J 2007; 29: 951-957 Year: 2007 Severe pulmonary hypertension in patients with emphysema but preserved FEV1: Prognosis and response to treatment Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Impact of borderline pulmonary arterial pressure on survival Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Daily monitoring parameters of arterial stiffness and central aortic pressure in COPD patients comorbid with arterial hypertension Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 Macitentan for pulmonary arterial hypertension (PAH): Early clinical experience of 94 patients Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Effects of pulmonary rehabilitation (PR) in idiopathic pulmonary arterial hypertension (PAHI) Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2) Year: 2013 The effects of beta-blocker therapy on systolic and diastolic function in pulmonary arterial hypertension: A randomized controlled trial Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH Year: 2014 Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016